Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 4/20 | 0.66 |
| ▸ | CDK9 | P50750 | 4/20 | 0.66 |
| ▸ | CDK2 | P24941 | 2/20 | 0.59 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.59 |
| ▸ | CDK4 | P11802 | 1/20 | 0.59 |
| ▸ | CCND1 | P24385 | 1/20 | 0.59 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.59 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 4/20 | 0.53 |
| ▸ | GSK3A | P49840 | 1/20 | 0.52 |
| ▸ | PIM1 | P11309 | 1/20 | 0.52 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7195024 | 0.89 | CCNT1 (0.76) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL29419482 | 0.82 | CCNT1 (0.61) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL7508106 | 0.82 | CCNT1 (0.61) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL6581547 | 0.82 | CCNT1 (0.61) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL29383914 | 0.82 | CCNT1 (0.61) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL6949072 | 0.82 | GSK3B (0.68) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL29349877 | 0.82 | GSK3B (0.68) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL29386790 | 0.81 | CCNT1 (0.60) | CCNT1CDK9CDK2CCNE2CDK4 | |
| SCHEMBL6099227 | 0.78 | CCNE2 (0.80) | CDK2CCNE2CDK4CCND1CCNE1 | |
| SCHEMBL1063235 | 0.77 | GSK3B (0.61) | CCNT1CDK9CDK2CCNE2CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888339-A4 | SYNTHESIS OF INDOLYLMALEIMIDES | LILLY CO ELI (US) | 2001-02-28 | — | — | EP | disclosed |
| US-6037475-A | REACTING OPTIONALLY SUBSTITUTED, N-PROTECTED INDOL-3-YL-ACETAMIDE WITH AN ALKYL OXALATE AND A STRONG ORGANIC BASE IN A POLAR APROTIC SOLVENT FORMING OPTIONALLY SUBSTITUTED 4-(INDOL-3-YL)-3-HYDROXY PYRROLE-2,5-DIONE | ELI LILLY & COMPANY (US) | 2000-03-14 | — | — | US | disclosed |
| US-5919946-A | REACTING AN ACTIVATED MALEIMIDE WITH AN ORGANOMETALLIC-3-INDOLE IN PRESENCE OF A PALLADIUM TRANSITION METAL CATALYST | ELI LILLY AND COMPANY (US) | 1999-07-06 | — | — | US | disclosed |
| US-5859261-A | PROTEIN KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1999-01-12 | — | — | US | disclosed |
| EP-0888339-A1 | SYNTHESIS OF INDOLYLMALEIMIDES | ELI LILLY AND COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034890-A1 | SYNTHESIS OF INDOLYLMALEIMIDES | ELI LILLY AND COMPANY (US) | 1997-09-25 | — | — | WO | disclosed |